These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7140004)

  • 61. [New aspects of the determination of blood methotrexate levels in leukemic children].
    Schuler D; Borsi J; Koós R; Révész T; Kardos G; Somló P
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):765-8. PubMed ID: 3467178
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of serum concentrations of methotrexate after various routes of administration.
    Freeman-Narrod M; Gerstley BJ; Engstrom PF; Bornstein RS
    Cancer; 1975 Nov; 36(5):1619-24. PubMed ID: 1192354
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-dose methotrexate: pharmacokinetics in children and young adults.
    Raude E; Oellerich M; Weinel P; Freund M; Schrappe M; Riehm H; Poliwoda H
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):364-70. PubMed ID: 3209285
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low-dose methotrexate kinetics in arthritis.
    Edelman J; Biggs DF; Jamali F; Russell AS
    Clin Pharmacol Ther; 1984 Mar; 35(3):382-6. PubMed ID: 6697645
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Bolus and maintenance infusion of high-dose methotrexate].
    Amino K; Kawaguchi N; Matsumoto S; Manabe J; Tabata D; Machida M
    Gan To Kagaku Ryoho; 1989 May; 16(5):2045-9. PubMed ID: 2730094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Concepts in use of high-dose methotrexate therapy.
    Treon SP; Chabner BA
    Clin Chem; 1996 Aug; 42(8 Pt 2):1322-9. PubMed ID: 8697606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Population pharmacokinetics of high-dose methotrexate after intravenous administration in Chinese osteosarcoma patients from a single institution.
    Zhang W; Zhang Q; Tian X; Zhao H; Lu W; Zhen J; Niu X
    Chin Med J (Engl); 2015 Jan; 128(1):111-8. PubMed ID: 25563323
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacodynamics of high-dose methotrexate in pediatric patients.
    Aquerreta I; Aldaz A; Giráldez J; Sierrasesúmaga L
    Ann Pharmacother; 2002 Sep; 36(9):1344-50. PubMed ID: 12196049
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of protein-calorie malnutrition on methotrexate pharmacokinetics.
    Charland SL; Bartlett D; Torosian MH
    JPEN J Parenter Enteral Nutr; 1994; 18(1):45-9. PubMed ID: 8164303
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.
    Milano G; Thyss A; Renee N; Schneider M; Namer M; Boublil JL; Lalanne CM
    Cancer Chemother Pharmacol; 1983; 11(1):29-32. PubMed ID: 6883624
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients.
    Zhang W; Zhang Q; Zheng TT; Zhen JC; Niu XH
    Chin Med J (Engl); 2016 Nov; 129(21):2530-2534. PubMed ID: 27779157
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum levels of methotrexate by the ligand-binding assay after "high-dose" therapy for osteosarcoma.
    Roberts D; Kidd W; Pratt CB; Peck C; Grinnel J
    Cancer; 1979 Sep; 44(3):881-90. PubMed ID: 314328
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
    Kimelberg HK; Biddlecome SM; Bourke RS
    Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Therapeutic effect of sequential doses of methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced gastric cancer: comparison of intermediate-dose MTX with high-dose MTX].
    Akazawa S; Nakajima T; Kitagawa H; Nakagawa T; Kanda Y; Futatsuki K; Suda Y; Yoshida S; Honda T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):91-8. PubMed ID: 3966810
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical experiences with high-dose methotrexate].
    Geissler K; Lenzhofer R; Schneeweiss B; Moser K
    Wien Klin Wochenschr; 1984 May; 96(10):381-9. PubMed ID: 6475060
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Tissue concentration of methotrexate in osteosarcoma after high-dose infusion].
    Amino K
    Nihon Seikeigeka Gakkai Zasshi; 1982 Aug; 56(8):765-76. PubMed ID: 6984057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.